Abnormal islet sphingolipid metabolism in type 1 diabetes

被引：0
|
作者：
Laurits J. Holm
Lars Krogvold
Jane P. Hasselby
Simranjeet Kaur
Laura A. Claessens
Mark A. Russell
Clayton E. Mathews
Kristian F. Hanssen
Noel G. Morgan
Bobby P. C. Koeleman
Bart O. Roep
Ivan C. Gerling
Flemming Pociot
Knut Dahl-Jørgensen
Karsten Buschard
机构：
[1] Rigshospitalet,The Bartholin Institute, Department of Pathology
[2] Copenhagen Biocenter,Division of Paediatric and Adolescent Medicine
[3] Oslo University Hospital,Faculty of Odontology
[4] University of Oslo,Department of Pathology
[5] Rigshospitalet,Department of Immunohaematology & Blood Transfusion
[6] Steno Diabetes Center Copenhagen,Department of Medical Genetics
[7] Leiden University Medical Center,Institute of Biomedical and Clinical Sciences
[8] University Medical Center,Department of Pathology
[9] University of Exeter Medical School,Department of Endocrinology
[10] University of Florida,Department of Diabetes Immunology, Diabetes & Metabolism Research Institute
[11] Oslo University Hospital,Department of Medicine
[12] Beckman Research Institute at the City of Hope,Faculty of Medicine
[13] University of Tennessee,undefined
[14] University of Oslo,undefined
来源：
Diabetologia | 2018年 / 61卷
关键词：
Fenofibrate; Gene polymorphisms; GWAS; Islet autoimmunity; NOD mice; Prevention; Sphingolipid; Sulfatide; T cells; Type 1 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1650 / 1661
页数：11
相关论文
共 50 条
  • [31] Abnormal Postprandial Metabolism in Children with Type 2 Diabetes Mellitus
    Rodriguez, Luisa M.
    Haymond, Morey W.
    Burrin, Douglas G.
    Holst, Jens J.
    Sunehag, Agneta
    Heptulla, Rubina A.
    DIABETES, 2009, 58 : A464 - A464
  • [32] Mechanisms for abnormal postprandial glucose metabolism in type 2 diabetes
    Woerle, HJ
    Szoke, E
    Meyer, C
    Dostou, JM
    Wittlin, SD
    Gosmanov, NR
    Welle, SL
    Gerich, JE
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2006, 290 (01): : E67 - E77
  • [33] Islet autoantibody response induced by islet allotransplantation in patients with type 1 diabetes
    Braghi, S
    Maffi, P
    Bertuzzi, F
    Monti, LD
    Secchi, A
    Pozza, G
    Bonifacio, E
    Bosi, E
    DIABETES, 2000, 49 : A87 - +
  • [34] Biomarkers in Islet Cell Transplantation for Type 1 Diabetes
    Fatimah T. AlRashidi
    Kathleen M. Gillespie
    Current Diabetes Reports, 2018, 18
  • [35] Islet cell transplantation and Type 1 diabetes mellitus
    White, SA
    Nicholson, ML
    DIABETIC MEDICINE, 2001, 18 : 6 - 9
  • [36] An Odyssey of Islet Transplantation for Therapy of Type 1 Diabetes
    Garth L. Warnock
    Yu Huan Theresa Liao
    Xiaojie Wang
    Dawei Ou
    Ziliang Ao
    James D. Johnson
    C. B. Verchere
    David Thompson
    World Journal of Surgery, 2007, 31 : 1569 - 1576
  • [37] Biomarkers in Islet Cell Transplantation for Type 1 Diabetes
    AlRashidi, Fatimah T.
    Gillespie, Kathleen M.
    CURRENT DIABETES REPORTS, 2018, 18 (10)
  • [38] The environment and the origins of islet autoimmunity and Type 1 diabetes
    Regnell, S. Eringsmark
    Lernmark, A.
    DIABETIC MEDICINE, 2013, 30 (02) : 155 - 160
  • [39] Patient Perceptions of Islet Transplantation for Type 1 Diabetes
    Fung, Michelle A.
    Barts, Agnieszka
    Thompson, David M.
    Ransom, Thomas P. P.
    Elliott, Tom G.
    Sirrs, Sandra M.
    Ur, Ehud
    CANADIAN JOURNAL OF DIABETES, 2010, 34 (03) : 203 - 210
  • [40] Autoantibody response to islet transplantation in type 1 diabetes
    Bosi, E
    Braghi, S
    Maffi, P
    Scirpoli, M
    Bertuzzi, F
    Pozza, G
    Secchi, A
    Bonifacio, E
    DIABETES, 2001, 50 (11) : 2464 - 2471
12345